PLX Return on Tangible Equity | Protalix BioTherapeutics, Inc.

Protalix BioTherapeutics, Inc. (PLX) Return on Tangible Equity

2026-06-30: Return Tang Equity 26.53%.
2026-03-31: Return Tang Equity 22.81%.
2025-12-31: Return Tang Equity -13.69%.
2025-09-30: Return Tang Equity 10.20%.

Complete source-backed return tang equity history.

Available history: 2009-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	26.53%
2026-03-31	22.81%
2025-12-31	-13.69%
2025-09-30	10.20%
2025-06-30	12.57%
2025-03-31	8.64%
2024-12-31	6.79%
2024-09-30	-29.61%
2024-06-30	-51.41%
2024-03-31	22.99%
2023-12-31	24.76%
2023-09-30	27.76%
2023-06-30	22.82%
2023-03-31	-1564.68%
2022-12-31	140.29%
2022-09-30	155.06%
2022-06-30	186.93%
2022-03-31	325.85%
2021-12-31	456.96%
2021-09-30	-9632.86%
2021-06-30	-540.38%
2021-03-31	-94.22%
2020-12-31	24.13%
2020-09-30	19.90%
2020-06-30	16.55%
2020-03-31	30.26%
2019-12-31	25.99%
2019-09-30	33.88%
2019-06-30	38.18%
2019-03-31	44.24%
2018-12-31	50.03%
2018-09-30	71.60%
2018-06-30	94.62%
2018-03-31	88.97%
2017-12-31	283.26%
2017-09-30	279.08%
2017-06-30	331.97%
2017-03-31	116.72%
2016-12-31	294.92%
2016-09-30	-305.63%
2016-06-30	-622.23%
2016-03-31	2090.98%
2015-12-31	533.77%
2015-09-30	34.06%
2015-06-30	42.25%
2015-03-31	46.72%
2014-12-31	53.85%
2014-09-30	67.85%
2014-06-30	75.64%
2014-03-31	91.77%
2013-12-31	103.13%
2013-09-30	160.31%
2013-06-30	221.21%
2013-03-31	159.72%
2012-12-31	346.08%
2012-09-30	-223.26%
2012-06-30	-178.68%
2012-03-31	578.92%
2011-12-31	140.08%
2011-09-30	208.29%
2011-06-30	341.76%
2011-03-31	-554.62%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-13.69%
2024-12-31	6.79%
2023-12-31	24.76%
2022-12-31	140.29%
2021-12-31	456.96%
2020-12-31	24.13%
2019-12-31	25.99%
2018-12-31	50.03%
2017-12-31	283.26%
2016-12-31	294.92%
2015-12-31	533.77%
2014-12-31	53.85%
2013-12-31	103.13%
2012-12-31	346.08%
2011-12-31	140.08%
2010-12-31	256.10%
2009-12-31	-197.95%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
ANAVEX LIFE SCIENCES CORP. (AVXL)	United States	$0.218B	-18.37
Alector, Inc. (ALEC)	United States	$0.213B	-1.90
Compass Therapeutics, Inc. (CMPX)	United States	$0.204B	-5.35
Aligos Therapeutics, Inc. (ALGS)	United States	$0.238B	-0.47
Lineage Cell Therapeutics, Inc. (LCTX)	United States	$0.241B	-10.35
Protara Therapeutics, Inc. (TARA)	United States	$0.198B	-3.22
Alpha Cognition Inc. (ACOG)		$0.185B	-6.77
Coherus Oncology, Inc. (CHRS)	United States	$0.182B	-1.63
SUTRO BIOPHARMA, INC. (STRO)	United States	$0.260B	-3.05
PRECISION BIOSCIENCES INC (DTIL)	United States	$0.175B	-3.95